# Emergent BioSolutions Inc. (EBS) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $100M |
| 2024 | -$109M |
| 2023 | -$726M |
| 2022 | -$170M |
| 2021 | $341M |
| 2020 | $439M |
| 2019 | $114M |
| 2018 | $90M |
| 2017 | $124M |
| 2016 | $106M |
| 2015 | $142M |
| 2014 | $89M |
| 2013 | $43M |
| 2012 | $30M |
| 2011 | $32M |
| 2010 | $74M |
| 2009 | $40M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $11M |
| 2025-09-30 | $77M |
| 2025-06-30 | $2M |
| 2025-03-31 | $50M |
| 2024-09-30 | $65M |
| 2024-06-30 | -$204M |
| 2024-03-31 | $40M |
| 2023-09-30 | -$242M |
| 2023-06-30 | -$293M |
| 2023-03-31 | -$148M |
| 2022-09-30 | -$45M |
| 2022-06-30 | -$76M |
| 2022-03-31 | $7M |
| 2021-09-30 | -$35M |
| 2021-06-30 | $15M |
| 2021-03-31 | $95M |
| 2020-09-30 | $61M |
| 2020-06-30 | $126M |
| 2020-03-31 | -$12M |
| 2019-09-30 | $71M |
| 2019-06-30 | -$7M |
| 2019-03-31 | -$27M |
| 2018-09-30 | $21M |
| 2018-06-30 | $67M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/EBS/operating-income)